ATE133335T1 - Neuroprotektivum - Google Patents

Neuroprotektivum

Info

Publication number: ATE133335T1
Authority: AT; Austria
Prior art keywords: cerebral; neuroprotection; neuroprotecting; distrubance; pyrrol
Prior art date: 1992-02-25

Application number

AT93102957T

Other languages

English (en)

Inventor

Noriko Yamamoto

Koichi Yokota

Akira Yamashita

Keizo Ito

Original Assignee

Kanebo Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-02-25

Filing date

1993-02-25

Publication date

1996-02-15

1993-02-25 Application filed by Kanebo Ltd filed Critical Kanebo Ltd

1996-02-15 Application granted granted Critical

1996-02-15 Publication of ATE133335T1 publication Critical patent/ATE133335T1/de

Links

230000004112 neuroprotection Effects 0.000 title 1
206010008111 Cerebral haemorrhage Diseases 0.000 abstract 1
206010021143 Hypoxia Diseases 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
230000005978 brain dysfunction Effects 0.000 abstract 1
230000002490 cerebral effect Effects 0.000 abstract 1
206010008118 cerebral infarction Diseases 0.000 abstract 1
208000026106 cerebrovascular disease Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
-1 ethyl 2-[4,5-bis(4-methoxyphenyl)thiazol-2-yl]pyrrol-1-yl Chemical group 0.000 abstract 1
230000007954 hypoxia Effects 0.000 abstract 1
238000011321 prophylaxis Methods 0.000 abstract 1
238000011282 treatment Methods 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Organic Chemistry (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Plural Heterocyclic Compounds (AREA)

AT93102957T 1992-02-25 1993-02-25 Neuroprotektivum ATE133335T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP4075256A JPH05229943A (ja)	1992-02-25	1992-02-25	脳保護剤

Publications (1)

Publication Number	Publication Date
ATE133335T1 true ATE133335T1 (de)	1996-02-15

Family

ID=13570960

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93102957T ATE133335T1 (de)	1992-02-25	1993-02-25	Neuroprotektivum

Country Status (9)

Country	Link
US (1)	US5399571A (de)
EP (1)	EP0560136B1 (de)
JP (1)	JPH05229943A (de)
KR (1)	KR100247845B1 (de)
AT (1)	ATE133335T1 (de)
DE (1)	DE69301360T2 (de)
DK (1)	DK0560136T3 (de)
ES (1)	ES2085665T3 (de)
GR (1)	GR3018787T3 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7462635B2 (en)	2002-03-14	2008-12-09	Takeda Pharmaceutical Company Limited	Thiazole and oxazole VDAC regulator
JP4484439B2 (ja) *	2002-03-14	2010-06-16	国立大学法人東京工業大学	Ｖｄａｃ調節剤
US9289168B2 (en) *	2008-12-29	2016-03-22	Medtronic Minimed, Inc.	System and/or method for glucose sensor calibration
US10471207B2 (en)	2008-12-29	2019-11-12	Medtronic Minimed, Inc.	System and/or method for glucose sensor calibration

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4168315A (en) *	1977-09-28	1979-09-18	The Upjohn Company	Dianisyl thiazole compound, compositions and method of antithrombotic treatment
US4659726A (en) *	1984-04-19	1987-04-21	Kanebo, Ltd.	Novel 4,5-Bis (4-methoxyphenyl)-2-(pyrrol-2-yl) thiazoles and pharmaceutical composition containing the same

1992
- 1992-02-25 JP JP4075256A patent/JPH05229943A/ja active Pending
1993
- 1993-02-12 US US08/016,860 patent/US5399571A/en not_active Expired - Fee Related
- 1993-02-24 KR KR1019930002589A patent/KR100247845B1/ko not_active Expired - Fee Related
- 1993-02-25 DK DK93102957.3T patent/DK0560136T3/da active
- 1993-02-25 EP EP93102957A patent/EP0560136B1/de not_active Expired - Lifetime
- 1993-02-25 ES ES93102957T patent/ES2085665T3/es not_active Expired - Lifetime
- 1993-02-25 AT AT93102957T patent/ATE133335T1/de not_active IP Right Cessation
- 1993-02-25 DE DE69301360T patent/DE69301360T2/de not_active Expired - Fee Related
1996
- 1996-01-25 GR GR950403720T patent/GR3018787T3/el unknown

Also Published As

Publication number	Publication date
DE69301360D1 (de)	1996-03-07
EP0560136A1 (de)	1993-09-15
KR100247845B1 (ko)	2000-04-01
DK0560136T3 (da)	1996-02-26
EP0560136B1 (de)	1996-01-24
ES2085665T3 (es)	1996-06-01
US5399571A (en)	1995-03-21
GR3018787T3 (en)	1996-04-30
KR930017579A (ko)	1993-09-20
JPH05229943A (ja)	1993-09-07
DE69301360T2 (de)	1996-07-11

Similar Documents

Publication	Publication Date	Title
FI933946A7 (fi)	1994-03-11	Hypoglykeemisinä aineina ja Alzheimerin taudin hoidossa käyttökelpoisia yhdisteitä
FI935306A7 (fi)	1994-06-17	Puhdistettujen, pintaa modifioivien aineiden käyttö estämään hiukkasten kasautumista steriloinnin aikana
ITTO910281A0 (it)	1991-04-12	Procedimento per l'ossidazione di carboidrati
KR950702564A (ko)	1995-07-29	비스-스타우로스포린 및 케이-252에이(K-25a)유도체(BIS-STAUROSPORINE AND K-252a DERIVATIVES)
KR930703355A (ko)	1993-11-29	항생물질 ge2270 인자의 아미드
EP0564924A3 (en)	1993-12-29	2-oxoethyl derivatives as immunosuppressants
AU3951389A (en)	1990-03-29	The use of alpha-amino boronicacid derivatives for the prophylaxis and treatment of virus diseases
NO302523B1 (no)	1998-03-16	Heterosykliske forbindelser, farmasöytiske preparater som omfatter dem, og anvendelse av forbindelsene for fremstilling av medikamenter
FI933902A7 (fi)	1994-03-10	Substituoidut sykloheksaanijohdannaiset sairauksien hoitamiseksi
NO943521D0 (no)	1994-09-22	Anvendelse av et pyrrolidinacetamidderivat for fremstilling av et terapeutikum
GR3022801T3 (en)	1997-06-30	Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
FI951511L (fi)	1995-03-30	IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
ATE133335T1 (de)	1996-02-15	Neuroprotektivum
IT9019101A0 (it)	1990-01-19	Procedimento per la stabilizzazione particolarmente di mosto d'uva
IT1271567B (it)	1997-05-30	Procedimento per l'ulteriore trattamento di salcicce
AU1450392A (en)	1992-10-21	Small peptidic compounds useful for the treatment of glaucoma
ATE183088T1 (de)	1999-08-15	Arzneimittel zur behandlung von hauterkrankungen
ATE75399T1 (de)	1992-05-15	Therapeutikum zur behandlung von magengeschwueren.
NO970185D0 (no)	1997-01-15	Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
NO920313D0 (no)	1992-01-23	Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
GR3022706T3 (en)	1997-05-31	Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
DE68901172D1 (de)	1992-05-14	(-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend.
HU908017D0 (en)	1991-06-28	Process for the preparation of naphloxazines and medical preparation made of them
BR9205712A (pt)	1994-06-07	Medicamento e processo para a preparaçao de um medicamento
FR2691064B3 (fr)	1996-01-12	Nouveau medicament pour le traitement de l'arythmie.

Legal Events

Date	Code	Title	Description
1996-08-15	UEP	Publication of translation of european patent specification
2000-11-15	REN	Ceased due to non-payment of the annual fee